ABBOTT PARK, Ill., April 29, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved AndroGel® (testosterone gel) 1.62%, a clear, odorless ...

AbbVie has scored a major reduction of damages in a retrial of an AndroGel liability case. After a judge nixed the initial verdict of $150 million and sent the case back for retrial, a jury this week ...

(Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug ...

(Bloomberg) — Abbott Laboratories and AbbVie Inc., the company it spun off last year, hid the dangers of using the testosterone replacement drug AndroGel, five men claimed in lawsuits. Their ...

The Federal Trade Commission is suing drugmakers AbbVie and Teva, saying they conspired to temporarily keep generic versions of AbbVie's low-testosterone drug AndroGel off the market. The FTC says ...

AbbVie notched a win late last month in its ongoing battle against thousands of lawsuits that claim AndroGel, a once-blockbuster drug marketed to treat low testosterone in men, causes heart attacks, ...

ATLANTA (CN) - A federal judge dismissed the remaining claims in a nearly 10-year-old dispute over competition on AndroGel, a drug that boosts testosterone production. In the 1990s, Unimed ...

A federal jury on Monday ordered AbbVie to pay $3.2 million to an Oregon man who claims the testosterone replacement drug AndroGel caused him to suffer a heart attack, a far smaller penalty than the ...

AbbVie Inc (NYSE:ABBV) has petitioned the U.S. Supreme Court to protect its corporate records, arguing that a lower court ruling threatens the confidentiality of attorney communications. The ...

YONKERS, N.Y., May 20 (UPI) -- Investigators at Consumer Reports say the directions for testosterone gel say the gel is flammable until dry and avoid smoking or an open flame until dry. Consumer ...